Mega Contracts Monitor ($100M+) — July 20, 2026

Leidos Biomedical Research won a $4.81B contract from HHS, representing 93% of total digest value and a strong bullish signal (7/10) for Leidos' government health services segment.

Cardinal Intellectual Property secured a $192M firm-fixed-price contract from the USPTO with a 13-year performance period, offering long-term revenue visibility but with zero outlayed funds to date.

UnitedHealth Group subsidiary OptumServe completed $175.7M of a $190M VA contract for medical disability exams, indicating strong execution but leaving no remaining option periods.

Cardinal Intellectual Property's $192M USPTO contract has $0 outlayed despite a 13-year performance period (2012-2025), raising questions about contract activation or revenue recognition.

Leidos Biomedical Research's $4.81B award from HHS represents 93% of total digest value, creating extreme single-contract concentration risk for the company's government health portfolio.

OptumServe's $190M VA contract is fully executed with no option periods, exposing UnitedHealth Group to recompetition risk for future VA disability examination contracts in the Southeast region.

Leidos Biomedical Research's $4.81B HHS contract signals growing government investment in biomedical research outsourcing, creating expansion opportunities for Leidos in health-related civilian agencies.

Cardinal Intellectual Property's 13-year USPTO contract provides a stable revenue base for professional services firms targeting intellectual property administration, a fee-funded agency less vulnerable to appropriations risk.

OptumServe's successful execution of a $190M VA contract positions UnitedHealth Group for follow-on work in veteran disability examinations, a recurring need tied to veteran benefits.

The $4.81B Leidos HHS award and $190M OptumServe VA contract demonstrate sustained government demand for outsourced health and biomedical services, with $5.0B in total health-related obligations.

Both the Cardinal Intellectual Property (13-year) and OptumServe (1-year) contracts are firm-fixed-price, transferring cost risk to contractors but offering predictable revenue for efficient operators.

{"entity"=>"Leidos Holdings (LDOS)", "reason"=>"The $4.81B HHS contract is a massive single-award that could materially impact Leidos' health segment revenue, but lacks detailed contract terms.", "trigger"=>"Leidos Q3 2026 earnings call for contract revenue recognition details"}

{"entity"=>"Cardinal Intellectual Property Inc.", "reason"=>"The $192M USPTO contract has zero outlayed funds, suggesting potential activation issues or delayed revenue recognition.", "trigger"=>"USASpending.gov update showing first outlayed amount or contract modification"}

{"entity"=>"UnitedHealth Group (UNH)", "reason"=>"OptumServe's VA contract is fully executed, creating recompetition risk for future disability exam contracts.", "trigger"=>"VA release of new solicitation for Region 2 medical disability examinations"}